Some factors that affect the prognosis of patients with high-grade glioma, such as age, histological type, single or multiple gliomas, extent of resection, MGMT methylation status, and Ki-67 level, were verified in our results (27–32). This evidence concerns the gene MKI67 and central nervous system cancer.